Global LFA-based Cardiac Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Troponin I
1.2.3 Troponin T
1.2.4 CK-MB
1.2.5 Myoglobin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global LFA-based Cardiac Revenue Market Share by Region (2020-2025)
2.4 Global LFA-based Cardiac Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America LFA-based Cardiac Market Size and Prospective (2020-2031)
2.5.2 Europe LFA-based Cardiac Market Size and Prospective (2020-2031)
2.5.3 China LFA-based Cardiac Market Size and Prospective (2020-2031)
2.5.4 Japan LFA-based Cardiac Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global LFA-based Cardiac Historic Market Size by Type (2020-2025)
3.2 Global LFA-based Cardiac Forecasted Market Size by Type (2026-2031)
3.3 Different Types LFA-based Cardiac Representative Players
4 Breakdown Data by Application
4.1 Global LFA-based Cardiac Historic Market Size by Application (2020-2025)
4.2 Global LFA-based Cardiac Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in LFA-based Cardiac Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top LFA-based Cardiac Players by Revenue (2020-2025)
5.1.2 Global LFA-based Cardiac Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by LFA-based Cardiac Revenue
5.4 Global LFA-based Cardiac Market Concentration Analysis
5.4.1 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Revenue in 2024
5.5 Global Key Players of LFA-based Cardiac Head office and Area Served
5.6 Global Key Players of LFA-based Cardiac, Product and Application
5.7 Global Key Players of LFA-based Cardiac, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America LFA-based Cardiac Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America LFA-based Cardiac Market Size by Type (2020-2025)
6.1.2.2 North America LFA-based Cardiac Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America LFA-based Cardiac Market Size by Application (2020-2025)
6.1.3.2 North America LFA-based Cardiac Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe LFA-based Cardiac Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe LFA-based Cardiac Market Size by Type (2020-2025)
6.2.2.2 Europe LFA-based Cardiac Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe LFA-based Cardiac Market Size by Application (2020-2025)
6.2.3.2 Europe LFA-based Cardiac Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China LFA-based Cardiac Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China LFA-based Cardiac Market Size by Type (2020-2025)
6.3.2.2 China LFA-based Cardiac Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China LFA-based Cardiac Market Size by Application (2020-2025)
6.3.3.2 China LFA-based Cardiac Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan LFA-based Cardiac Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan LFA-based Cardiac Market Size by Type (2020-2025)
6.4.2.2 Japan LFA-based Cardiac Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan LFA-based Cardiac Market Size by Application (2020-2025)
6.4.3.2 Japan LFA-based Cardiac Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Roche
7.1.1 Roche Company Details
7.1.2 Roche Business Overview
7.1.3 Roche LFA-based Cardiac Introduction
7.1.4 Roche Revenue in LFA-based Cardiac Business (2020-2025)
7.1.5 Roche Recent Development
7.2 Abbott
7.2.1 Abbott Company Details
7.2.2 Abbott Business Overview
7.2.3 Abbott LFA-based Cardiac Introduction
7.2.4 Abbott Revenue in LFA-based Cardiac Business (2020-2025)
7.2.5 Abbott Recent Development
7.3 Siemens
7.3.1 Siemens Company Details
7.3.2 Siemens Business Overview
7.3.3 Siemens LFA-based Cardiac Introduction
7.3.4 Siemens Revenue in LFA-based Cardiac Business (2020-2025)
7.3.5 Siemens Recent Development
7.4 Danaher
7.4.1 Danaher Company Details
7.4.2 Danaher Business Overview
7.4.3 Danaher LFA-based Cardiac Introduction
7.4.4 Danaher Revenue in LFA-based Cardiac Business (2020-2025)
7.4.5 Danaher Recent Development
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Company Details
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories LFA-based Cardiac Introduction
7.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2020-2025)
7.5.5 Bio-Rad Laboratories Recent Development
7.6 BioMérieux
7.6.1 BioMérieux Company Details
7.6.2 BioMérieux Business Overview
7.6.3 BioMérieux LFA-based Cardiac Introduction
7.6.4 BioMérieux Revenue in LFA-based Cardiac Business (2020-2025)
7.6.5 BioMérieux Recent Development
7.7 Thermo Fisher
7.7.1 Thermo Fisher Company Details
7.7.2 Thermo Fisher Business Overview
7.7.3 Thermo Fisher LFA-based Cardiac Introduction
7.7.4 Thermo Fisher Revenue in LFA-based Cardiac Business (2020-2025)
7.7.5 Thermo Fisher Recent Development
7.8 Ortho Clinical Diagnostics
7.8.1 Ortho Clinical Diagnostics Company Details
7.8.2 Ortho Clinical Diagnostics Business Overview
7.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Introduction
7.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2020-2025)
7.8.5 Ortho Clinical Diagnostics Recent Development
7.9 LSI Medience Corporation
7.9.1 LSI Medience Corporation Company Details
7.9.2 LSI Medience Corporation Business Overview
7.9.3 LSI Medience Corporation LFA-based Cardiac Introduction
7.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Business (2020-2025)
7.9.5 LSI Medience Corporation Recent Development
7.10 Randox laboratories
7.10.1 Randox laboratories Company Details
7.10.2 Randox laboratories Business Overview
7.10.3 Randox laboratories LFA-based Cardiac Introduction
7.10.4 Randox laboratories Revenue in LFA-based Cardiac Business (2020-2025)
7.10.5 Randox laboratories Recent Development
7.11 Wondfo Biotech
7.11.1 Wondfo Biotech Company Details
7.11.2 Wondfo Biotech Business Overview
7.11.3 Wondfo Biotech LFA-based Cardiac Introduction
7.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Business (2020-2025)
7.11.5 Wondfo Biotech Recent Development
7.12 EasyDiagnosis Biomedicine
7.12.1 EasyDiagnosis Biomedicine Company Details
7.12.2 EasyDiagnosis Biomedicine Business Overview
7.12.3 EasyDiagnosis Biomedicine LFA-based Cardiac Introduction
7.12.4 EasyDiagnosis Biomedicine Revenue in LFA-based Cardiac Business (2020-2025)
7.12.5 EasyDiagnosis Biomedicine Recent Development
8 LFA-based Cardiac Market Dynamics
8.1 LFA-based Cardiac Industry Trends
8.2 LFA-based Cardiac Market Drivers
8.3 LFA-based Cardiac Market Challenges
8.4 LFA-based Cardiac Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Global LFA-based Cardiac Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market LFA-based Cardiac Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global LFA-based Cardiac Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global LFA-based Cardiac Revenue Share by Region (2020-2025)
Table 6. Global LFA-based Cardiac Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global LFA-based Cardiac Revenue Share Forecast by Region (2026-2031)
Table 8. Global LFA-based Cardiac Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Table 10. Global LFA-based Cardiac Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global LFA-based Cardiac Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global LFA-based Cardiac Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Table 15. Global LFA-based Cardiac Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global LFA-based Cardiac Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in LFA-based Cardiac Application
Table 18. Global LFA-based Cardiac Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global LFA-based Cardiac Market Share by Players (2020-2025)
Table 20. Global Top LFA-based Cardiac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2024)
Table 21. Ranking of Global Top LFA-based Cardiac Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by LFA-based Cardiac Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of LFA-based Cardiac, Headquarters and Area Served
Table 24. Global Key Players of LFA-based Cardiac, Product and Application
Table 25. Global Key Players of LFA-based Cardiac, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America LFA-based Cardiac Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America LFA-based Cardiac Revenue Market Share by Company (2020-2025)
Table 29. North America LFA-based Cardiac Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America LFA-based Cardiac Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe LFA-based Cardiac Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe LFA-based Cardiac Revenue Market Share by Company (2020-2025)
Table 33. Europe LFA-based Cardiac Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe LFA-based Cardiac Market Size by Application (2020-2025) & (US$ Million)
Table 35. China LFA-based Cardiac Revenue by Company (2020-2025) & (US$ Million)
Table 36. China LFA-based Cardiac Revenue Market Share by Company (2020-2025)
Table 37. China LFA-based Cardiac Market Size by Type (2020-2025) & (US$ Million)
Table 38. China LFA-based Cardiac Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan LFA-based Cardiac Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan LFA-based Cardiac Revenue Market Share by Company (2020-2025)
Table 41. Japan LFA-based Cardiac Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan LFA-based Cardiac Market Size by Application (2020-2025) & (US$ Million)
Table 43. Roche Company Details
Table 44. Roche Business Overview
Table 45. Roche LFA-based Cardiac Product
Table 46. Roche Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 47. Roche Recent Development
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott LFA-based Cardiac Product
Table 51. Abbott Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Siemens Company Details
Table 54. Siemens Business Overview
Table 55. Siemens LFA-based Cardiac Product
Table 56. Siemens Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 57. Siemens Recent Development
Table 58. Danaher Company Details
Table 59. Danaher Business Overview
Table 60. Danaher LFA-based Cardiac Product
Table 61. Danaher Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 62. Danaher Recent Development
Table 63. Bio-Rad Laboratories Company Details
Table 64. Bio-Rad Laboratories Business Overview
Table 65. Bio-Rad Laboratories LFA-based Cardiac Product
Table 66. Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 67. Bio-Rad Laboratories Recent Development
Table 68. BioMérieux Company Details
Table 69. BioMérieux Business Overview
Table 70. BioMérieux LFA-based Cardiac Product
Table 71. BioMérieux Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 72. BioMérieux Recent Development
Table 73. Thermo Fisher Company Details
Table 74. Thermo Fisher Business Overview
Table 75. Thermo Fisher LFA-based Cardiac Product
Table 76. Thermo Fisher Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 77. Thermo Fisher Recent Development
Table 78. Ortho Clinical Diagnostics Company Details
Table 79. Ortho Clinical Diagnostics Business Overview
Table 80. Ortho Clinical Diagnostics LFA-based Cardiac Product
Table 81. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 82. Ortho Clinical Diagnostics Recent Development
Table 83. LSI Medience Corporation Company Details
Table 84. LSI Medience Corporation Business Overview
Table 85. LSI Medience Corporation LFA-based Cardiac Product
Table 86. LSI Medience Corporation Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 87. LSI Medience Corporation Recent Development
Table 88. Randox laboratories Company Details
Table 89. Randox laboratories Business Overview
Table 90. Randox laboratories LFA-based Cardiac Product
Table 91. Randox laboratories Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 92. Randox laboratories Recent Development
Table 93. Wondfo Biotech Company Details
Table 94. Wondfo Biotech Business Overview
Table 95. Wondfo Biotech LFA-based Cardiac Product
Table 96. Wondfo Biotech Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 97. Wondfo Biotech Recent Development
Table 98. EasyDiagnosis Biomedicine Company Details
Table 99. EasyDiagnosis Biomedicine Business Overview
Table 100. EasyDiagnosis Biomedicine LFA-based Cardiac Product
Table 101. EasyDiagnosis Biomedicine Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 102. EasyDiagnosis Biomedicine Recent Development
Table 103. LFA-based Cardiac Market Trends
Table 104. LFA-based Cardiac Market Drivers
Table 105. LFA-based Cardiac Market Challenges
Table 106. LFA-based Cardiac Market Restraints
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources


List of Figures
Figure 1. LFA-based Cardiac Product Picture
Figure 2. Global LFA-based Cardiac Market Share by Type: 2024 VS 2031
Figure 3. Troponin I Features
Figure 4. Troponin T Features
Figure 5. CK-MB Features
Figure 6. Myoglobin Features
Figure 7. Others Features
Figure 8. Global LFA-based Cardiac Market Share by Application: 2024 VS 2031
Figure 9. Laboratory Testing
Figure 10. Point-of-care Testing
Figure 11. LFA-based Cardiac Report Years Considered
Figure 12. Global LFA-based Cardiac Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global LFA-based Cardiac Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global LFA-based Cardiac Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America LFA-based Cardiac Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe LFA-based Cardiac Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China LFA-based Cardiac Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan LFA-based Cardiac Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global LFA-based Cardiac Market Share by Players in 2024
Figure 20. Global Top LFA-based Cardiac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by LFA-based Cardiac Revenue in 2024
Figure 22. North America LFA-based Cardiac Market Share by Type (2020-2025)
Figure 23. North America LFA-based Cardiac Market Share by Application (2020-2025)
Figure 24. Europe LFA-based Cardiac Market Share by Type (2020-2025)
Figure 25. Europe LFA-based Cardiac Market Share by Application (2020-2025)
Figure 26. China LFA-based Cardiac Market Share by Type (2020-2025)
Figure 27. China LFA-based Cardiac Market Share by Application (2020-2025)
Figure 28. Japan LFA-based Cardiac Market Share by Type (2020-2025)
Figure 29. Japan LFA-based Cardiac Market Share by Application (2020-2025)
Figure 30. Roche Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 31. Abbott Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 32. Siemens Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 33. Danaher Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 34. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 35. BioMérieux Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 36. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 37. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 38. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 39. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 40. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 41. EasyDiagnosis Biomedicine Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit